Chris Calabrese | IR, LifeSci Advisors |
Steven Shallcross | Chief Executive and CFO |
Dr. Manel Cascalló | General Director |
Dr. Vince Wacher | Head, Corporate and Product Development |
James Molloy | Alliance Global Partners |
Ladies and gentlemen, good morning, and welcome to the Theriva Biologics, Inc. 2023 Second Quarter Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Chris Calabrese from LifeSci Advisors. Please go ahead.